Abstract
Behavioural and psychological symptoms of dementia (BPSD) form a significant part of presentation in dementia. BPSD are more common in Alzheimer’s and frontotemporal dementia, and they persist all through the course of dementia. Pharmacological treatment includes cholinergic agents and some antipsychotics. Depression, paranoid symptoms, apathy, and withdrawal symptoms are predominant patterns in BPSD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73. https://doi.org/10.3389/fneur.2012.00073.
World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
Chiu MJ, Chen TF, Yip PK, Hua MS, Tang LY. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc. 2006;105:556–62.
Mukherjee A, Biswas A, Roy A, Biswas S, Gangopadhyay G, Das SK. Behavioural and psychological symptoms of dementia: correlates and impact on caregiver distress. Dement Geriatr Cogn Disord Extra. 2017;7:354–65.
Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci. 2001;28(Suppl 1):S96–107.
Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviours in dementia: a review, summary, and critique. Am J Geriatr Psychiatry. 2001;9(4):361–81.
Senanarong V, Cummings JL, Fairbanks L, Mega M, Masterman DM, O’Connor SM, et al. Agitation in Alzheimer’s disease is a manifestation of frontal lobe dysfunction. Dement Geriatr Cogn Disord. 2004;17(1–2):14–20.
Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry. 1987;48(Suppl):9–15.
Cheong JA. An evidence-based approach to the management of agitation in the geriatric patient. Focus. 2004;2:197–205.
Lishman WA. Organic psychiatry: the psychological consequences of cerebral disorder. Oxford: Blackwell Scientific Publication; 1987.
Kar N, Sengupta S, Sharma PS. Noncognitive abnormalities in dementia. Paper presented at 14th International Conference of Alzheimer’s Disease International, September 24–27, 1998, at Cochin.
Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviours in dementia: a review, summary, and critique. Focus. 2004;2:288–308.
Hall GR. Caring for people with Alzheimer’s disease using the conceptual model of progressively lowered stress threshold in the clinical setting. Nurs Clin North Am. 1994;29(1):129–41.
Boyle PA, Malloy PF. Treating apathy in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1–2):91–9.
Parnetti L, Amici S, Lanari A, Gallai V. Pharmacological treatment of non-cognitive disturbances in dementia disorders. Mech Ageing Dev. 2001;122(16):2063–9.
Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Mariën P, Somers N, et al. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem Int. 2008;52(6):1052–60.
Dr. Si Ching LIM. Managing behavioral and psychological symptoms of dementia–from a geriatrician’s perspective. Singapore: Department of Geriatric Medicine, Changi General Hospital. Accepted 24 July 2017.
Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596–608.
Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996;8(Suppl 3):497–500.
Pautex S, Michon A, Guedira M, Emond H, Le Lous P, Samaras D, et al. Pain in severe dementia: self-assessment or observational scales. J Am Geriatr Soc. 2006;54(7):1040–5.
Lane P, Kuntupis M, MacDonald S, McCarthy P, Panke JA, Warden V, et al. A pain assessment tool for people with advanced Alzheimer’s and other progressive dementias. Home Healthc Nurse. 2003;21(1):32–7.
Daniel DG. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry. 2000;61(Suppl 14):49–52.
Stoppe G, Brandt CA, Staedt JH. Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging. 1999;14(1):41–54.
Lawlor BA. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics. J Clin Psychiatry. 2004;65(Suppl 11):5–10.
Zaudig M. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Saf. 2000;23(3):183–95.
Sloane PD, Hoeffer B, Mitchell CM, McKenzie DA, Barrick AL, Rader J, et al. Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial. J Am Geriatr Soc. 2004;52(11):1795–804.
Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934–43.
Kindermann SS, Dolder CR. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience. Drugs Aging. 2002;19(4):257–76.
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1154–66.
Hawkins JW, Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry. 2000;8(3):221–5.
Tariot PN, Erb R, Leibovici A, Podgorski CA, Cox C, Asnis J, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc. 1994;42(11):1160–6.
Kozman MN, Wattis J, Curran S. Pharmacological management of behavioural and psychological disturbance in dementia. Hum Psychopharmacol. 2006;21(1):1–12.
Pollock BG, Mulsant BH, Rosen J, Sweet RA, Mazumdar S, Bharucha A, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry. 2002;59(3):460–5.
Sultzer DL, Gray KF, Gunay I, Berisford MA, Mahler ME. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatr. 1997;5(1):60–9.
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004;291(3):317–24.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rao, G.P., Ponangi, C.D., Yelamanchali, S., Vemulakonda, S. (2020). Behavioural and Psychological Symptoms Occurring in Dementia. In: Shrivastava, A., De Sousa, A. (eds) Schizophrenia Treatment Outcomes. Springer, Cham. https://doi.org/10.1007/978-3-030-19847-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-19847-3_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19846-6
Online ISBN: 978-3-030-19847-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)